查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
白蛋白(輔料)的全球市場 - 產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)
市場調查報告書
商品編碼
1110321

白蛋白(輔料)的全球市場 - 產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)

Albumin (as Excipient) Market (Product Type: Human Serum Albumin and Recombinant Albumin; and Application: Human Serum Albumin and Recombinant Albumin) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

本報告提供全球白蛋白(輔料)市場相關調查分析，提供市場趨勢，市場區隔分析，地區分析，企業簡介等資訊。

目錄

第1章 序文

第2章 與前提調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 全球白蛋白(輔料)市場預測
  • 全球白蛋白(輔料)市場預測

第5章 市場預測

  • 主要的產業的活動(合併·收購·夥伴關係·聯盟等)
  • 技術的進步
  • COVID-19對產業的COVID-19大流行病的影響(價值鏈，短期·中期·長期的影響)

第6章 全球白蛋白(輔料)市場分析與預測:各產品類型

  • 全球白蛋白(輔料)市場分析與預測:各產品類型
  • 簡介
  • 全球白蛋白(輔料)市場金額佔有率和魅力的分析:各產品類型
  • 全球白蛋白(輔料)市場預測:各產品類型
    • 人血清白蛋白
    • 重組的白蛋白
  • 全球白蛋白(輔料)市場分析:各產品類型

第7章 全球白蛋白(輔料)市場分析與預測:各用途

  • 簡介
  • 全球白蛋白(輔料)市場金額佔有率和魅力的分析:各用途
  • 全球白蛋白(輔料)市場預測:各用途
    • 人血清白蛋白的用途
    • 重組的白蛋白
  • 全球白蛋白(輔料)市場分析:各用途

第8章 全球白蛋白(輔料)市場分析與預測:各終端用戶

  • 簡介
  • 全球白蛋白(輔料)市場金額佔有率和魅力的分析:各終端用戶
  • 全球白蛋白(輔料)市場預測:各終端用戶
    • 製藥·生物科技產業
    • 研究機關
    • 其他
  • 全球白蛋白(輔料)市場分析:各終端用戶

第9章 全球白蛋白(輔料)市場分析與預測:各地區

  • 全球白蛋白(輔料)市場分析:各地區
  • 全球白蛋白(輔料)市場金額佔有率和魅力的分析:各地區
  • 全球白蛋白(輔料)市場預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲

第10章 北美的白蛋白(輔料)市場分析

第11章 歐洲的白蛋白(輔料)市場分析

第12章 亞太地區的白蛋白(輔料)市場分析

第13章 南美的白蛋白(輔料)市場分析

第14章 中東·非洲的白蛋白(輔料)市場分析

第15章 競爭情形

  • 市場企業 - 競爭矩陣:階層·不同企業規模
  • 市場佔有率分析/排行榜:各企業(2021年)
  • 企業簡介
    • Albumedix Ltd.
    • Albumin Therapeutics, LLC (Albumin Bioscience)
    • Biotest AG
    • CSL Behring (CSL)
    • Grifols, SA
    • HiMedia Laboratories
    • InVitria
    • Medxbio Pte Ltd
    • Octapharma AG
    • RayBiotech, Inc.
    • SeraCare Life Sciences
    • Sigma-Aldrich Co. (Merck KGaA)
    • Takeda Pharmaceutical Company Limited (Shire)
Product Code: TMRGL3984

The report provides revenue of the global albumin (as excipient) market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global albumin (as excipient) market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the albumin (as excipient) market.

The report delves into the competitive landscape of the global albumin (as excipient) market. Key players operating in the global albumin (as excipient) market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global albumin (as excipient) market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions and Acronyms Used
  • 2.2. Research Methodology

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunity
  • 4.3. Global Albumin (as Excipient) Market Forecast
  • 4.4. Global Albumin (as Excipient) Market Outlook

5. Market Outlook

  • 5.1. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
  • 5.2. Technological Advancement
  • 5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Albumin (as Excipient) Market Analysis and Forecast, by Product Type

  • 6.1. Global Albumin (as Excipient) Market Analysis and Forecast, by Product Type
  • 6.2. Introduction
  • 6.3. Global Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
  • 6.4. Global Albumin (as Excipient) Market Forecast, by Product Type
    • 6.4.1. Human Serum Albumin
    • 6.4.2. Recombinant Albumin
  • 6.5. Global Albumin (as Excipient) Market Analysis, by Product Type

7. Global Albumin (as Excipient) Market Analysis and Forecast, by Application

  • 7.1. Introduction
  • 7.2. Global Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
  • 7.3. Global Albumin (as Excipient) Market Forecast, by Application
    • 7.3.1. Human Serum Albumin Applications
      • 7.3.1.1. Drug Formulation
      • 7.3.1.2. Drug Delivery
      • 7.3.1.3. Vaccines
      • 7.3.1.4. Medical Device Coating
      • 7.3.1.5. Culture Medium & Stabilizer
      • 7.3.1.6. Diagnostics
      • 7.3.1.7. In Vitro Fertilization
    • 7.3.2. Recombinant Albumin
      • 7.3.2.1. Drug Formulation
      • 7.3.2.2. Drug Delivery
      • 7.3.2.3. Vaccines
      • 7.3.2.4. Medical Device Coating
      • 7.3.2.5. Culture Medium & Stabilizer
      • 7.3.2.6. Diagnostics
      • 7.3.2.7. In Vitro Fertilization
  • 7.4. Global Albumin (as Excipient) Market Analysis, by Application

8. Global Albumin (as Excipient) Market Analysis and Forecast, by End-user

  • 8.1. Introduction
  • 8.2. Global Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
  • 8.3. Global Albumin (as Excipient) Market Forecast, by End-user
    • 8.3.1. Pharmaceutical & Biotechnology Industry
    • 8.3.2. Research Institutes
    • 8.3.3. Others
  • 8.4. Global Albumin (as Excipient) Market Analysis, by End-user

9. Global Albumin (as Excipient) Market Analysis and Forecast, by Region

  • 9.1. Global Albumin (as Excipient) Market Analysis, by Region
  • 9.2. Global Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Region
  • 9.3. Global Albumin (as Excipient) Market Forecast, by Region
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa

10. North America Albumin (as Excipient) Market Analysis

  • 10.1. North America Albumin (as Excipient) Market Overview
  • 10.2. North America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Country
  • 10.3. North America Albumin (as Excipient) Market Forecast, by Country
    • 10.3.1. U.S.
    • 10.3.2. Canada
  • 10.4. North America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
  • 10.5. North America Albumin (as Excipient) Market Forecast, by Product Type
    • 10.5.1. Human Serum Albumin
    • 10.5.2. Recombinant Albumin
  • 10.6. North America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
  • 10.7. North America Albumin (as Excipient) Market Forecast, by Application
    • 10.7.1. Human Serum Albumin Applications
      • 10.7.1.1. Drug Formulation
      • 10.7.1.2. Drug Delivery
      • 10.7.1.3. Vaccines
      • 10.7.1.4. Medical Device Coating
      • 10.7.1.5. Culture Medium & Stabilizer
      • 10.7.1.6. Diagnostics
      • 10.7.1.7. In Vitro Fertilization
    • 10.7.2. Recombinant Albumin
      • 10.7.2.1. Drug Formulation
      • 10.7.2.2. Drug Delivery
      • 10.7.2.3. Vaccines
      • 10.7.2.4. Medical Device Coating
      • 10.7.2.5. Culture Medium & Stabilizer
      • 10.7.2.6. Diagnostics
      • 10.7.2.7. In Vitro Fertilization
  • 10.8. North America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
  • 10.9. North America Albumin (as Excipient) Market Forecast, by End-user
    • 10.9.1. Pharmaceutical & Biotechnology Industry
    • 10.9.2. Research Institutes
    • 10.9.3. Others

11. Europe Albumin (as Excipient) Market Analysis

  • 11.1. Europe Albumin (as Excipient) Market Overview
  • 11.2. Europe Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Countries/Sub-region
  • 11.3. Europe Albumin (as Excipient) Market Forecast, by Countries/Sub-region
    • 11.3.1. Germany
    • 11.3.2. France
    • 11.3.3. U.K.
    • 11.3.4. Italy
    • 11.3.5. Spain
    • 11.3.6. Rest of Europe
  • 11.4. Europe Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
  • 11.5. Europe Albumin (as Excipient) Market Forecast, by Product Type
    • 11.5.1. Human Serum Albumin
    • 11.5.2. Recombinant Albumin
  • 11.6. Europe Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
  • 11.7. Europe Albumin (as Excipient) Market Forecast, by Application
    • 11.7.1. Human Serum Albumin Applications
      • 11.7.1.1. Drug Formulation
      • 11.7.1.2. Drug Delivery
      • 11.7.1.3. Vaccines
      • 11.7.1.4. Medical Device Coating
      • 11.7.1.5. Culture Medium & Stabilizer
      • 11.7.1.6. Diagnostics
      • 11.7.1.7. In Vitro Fertilization
    • 11.7.2. Recombinant Albumin
      • 11.7.2.1. Drug Formulation
      • 11.7.2.2. Drug Delivery
      • 11.7.2.3. Vaccines
      • 11.7.2.4. Medical Device Coating
      • 11.7.2.5. Culture Medium & Stabilizer
      • 11.7.2.6. Diagnostics
      • 11.7.2.7. In Vitro Fertilization
  • 11.8. Europe Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
  • 11.9. Europe Albumin (as Excipient) Market Forecast, by End-user
    • 11.9.1. Pharmaceutical & Biotechnology Industry
    • 11.9.2. Research Institutes
    • 11.9.3. Others

12. Asia Pacific Albumin (as Excipient) Market Analysis

  • 12.1. Asia Pacific Albumin (as Excipient) Market Overview
  • 12.2. Asia Pacific Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Countries/Sub-region
  • 12.3. Asia Pacific Albumin (as Excipient) Market Forecast, by Countries/Sub-region
    • 12.3.1. Japan
    • 12.3.2. China
    • 12.3.3. India
    • 12.3.4. Australia & New Zealand
    • 12.3.5. Rest of Asia Pacific
  • 12.4. Asia Pacific Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
  • 12.5. Asia Pacific Albumin (as Excipient) Market Forecast, by Product Type
    • 12.5.1. Human Serum Albumin
    • 12.5.2. Recombinant Albumin
  • 12.6. Asia Pacific Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
  • 12.7. Asia Pacific Albumin (as Excipient) Market Forecast, by Application
    • 12.7.1. Human Serum Albumin Applications
      • 12.7.1.1. Drug Formulation
      • 12.7.1.2. Drug Delivery
      • 12.7.1.3. Vaccines
      • 12.7.1.4. Medical Device Coating
      • 12.7.1.5. Culture Medium & Stabilizer
      • 12.7.1.6. Diagnostics
      • 12.7.1.7. In Vitro Fertilization
    • 12.7.2. Recombinant Albumin
      • 12.7.2.1. Drug Formulation
      • 12.7.2.2. Drug Delivery
      • 12.7.2.3. Vaccines
      • 12.7.2.4. Medical Device Coating
      • 12.7.2.5. Culture Medium & Stabilizer
      • 12.7.2.6. Diagnostics
      • 12.7.2.7. In Vitro Fertilization
  • 12.8. Asia Pacific Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
  • 12.9. Asia Pacific Albumin (as Excipient) Market Forecast, by End-user
    • 12.9.1. Pharmaceutical & Biotechnology Industry
    • 12.9.2. Research Institutes
    • 12.9.3. Others

13. Latin America Albumin (as Excipient) Market Analysis

  • 13.1. Latin America Albumin (as Excipient) Market Overview
  • 13.2. Latin America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Countries/Sub-region
  • 13.3. Latin America Albumin (as Excipient) Market Forecast, by Countries/Sub-region
    • 13.3.1. Brazil
    • 13.3.2. Mexico
    • 13.3.3. Rest of Latin America
  • 13.4. Latin America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
  • 13.5. Latin America Albumin (as Excipient) Market Forecast, by Product Type
    • 13.5.1. Human Serum Albumin
    • 13.5.2. Recombinant Albumin
  • 13.6. Latin America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
  • 13.7. Latin America Albumin (as Excipient) Market Forecast, by Application
    • 13.7.1. Human Serum Albumin Applications
      • 13.7.1.1. Drug Formulation
      • 13.7.1.2. Drug Delivery
      • 13.7.1.3. Vaccines
      • 13.7.1.4. Medical Device Coating
      • 13.7.1.5. Culture Medium & Stabilizer
      • 13.7.1.6. Diagnostics
      • 13.7.1.7. In Vitro Fertilization
    • 13.7.2. Recombinant Albumin
      • 13.7.2.1. Drug Formulation
      • 13.7.2.2. Drug Delivery
      • 13.7.2.3. Vaccines
      • 13.7.2.4. Medical Device Coating
      • 13.7.2.5. Culture Medium & Stabilizer
      • 13.7.2.6. Diagnostics
      • 13.7.2.7. In Vitro Fertilization
  • 13.8. Latin America Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
  • 13.9. Latin America Albumin (as Excipient) Market Forecast, by End-user
    • 13.9.1. Pharmaceutical & Biotechnology Industry
    • 13.9.2. Research Institutes
    • 13.9.3. Others

14. Middle East & Africa Albumin (as Excipient) Market Analysis

  • 14.1. Middle East & Africa Albumin (as Excipient) Market Overview
  • 14.2. Middle East & Africa Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Countries/Sub-region
  • 14.3. Middle East & Africa Albumin (as Excipient) Market Forecast, by Countries/Sub-region
    • 14.3.1. GCC Countries
    • 14.3.2. South Africa
    • 14.3.3. Rest of MEA
  • 14.4. Middle East & Africa Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Product Type
  • 14.5. Middle East & Africa Albumin (as Excipient) Market Forecast, by Product Type
    • 14.5.1. Human Serum Albumin
    • 14.5.2. Recombinant Albumin
  • 14.6. Middle East & Africa Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by Application
  • 14.7. Middle East & Africa Albumin (as Excipient) Market Forecast, by Application
    • 14.7.1. Human Serum Albumin Applications
      • 14.7.1.1. Drug Formulation
      • 14.7.1.2. Drug Delivery
      • 14.7.1.3. Vaccines
      • 14.7.1.4. Medical Device Coating
      • 14.7.1.5. Culture Medium & Stabilizer
      • 14.7.1.6. Diagnostics
      • 14.7.1.7. In Vitro Fertilization
    • 14.7.2. Recombinant Albumin
      • 14.7.2.1. Drug Formulation
      • 14.7.2.2. Drug Delivery
      • 14.7.2.3. Vaccines
      • 14.7.2.4. Medical Device Coating
      • 14.7.2.5. Culture Medium & Stabilizer
      • 14.7.2.6. Diagnostics
      • 14.7.2.7. In Vitro Fertilization
  • 14.8. Middle East & Africa Albumin (as Excipient) Market Value Share and Attractiveness Analysis, by End-user
  • 14.9. Middle East & Africa Albumin (as Excipient) Market Forecast, by End-user
    • 14.9.1. Pharmaceutical & Biotechnology Industry
    • 14.9.2. Research Institutes
    • 14.9.3. Others

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis/Ranking, by Company, 2021
  • 15.3. Company Profiles
    • 15.3.1. Albumedix Ltd.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Albumin Therapeutics, LLC (Albumin Bioscience)
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Biotest AG
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. CSL Behring (CSL)
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Grifols, S.A.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. HiMedia Laboratories
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. InVitria
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Medxbio Pte Ltd
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Octapharma AG
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. RayBiotech, Inc.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview
    • 15.3.11. SeraCare Life Sciences
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. SWOT Analysis
      • 15.3.11.5. Strategic Overview
    • 15.3.12. Sigma-Aldrich Co. (Merck KGaA)
      • 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. Financial Overview
      • 15.3.12.4. SWOT Analysis
      • 15.3.12.5. Strategic Overview
    • 15.3.13. Takeda Pharmaceutical Company Limited (Shire)
      • 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.13.2. Product Portfolio
      • 15.3.13.3. Financial Overview
      • 15.3.13.4. SWOT Analysis
      • 15.3.13.5. Strategic Overview

List of Tables

  • Table 01: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Product Type, 2017-2031
  • Table 03: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Application, 2017-2031
  • Table 05: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2017-2031
  • Table 06: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2017-2031
  • Table 07: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 08: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 09: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 10: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 11: Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Region, 2017-2031
  • Table 12: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 13: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Product Type, 2017-2031
  • Table 16: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2017-2031
  • Table 17: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2017-2031
  • Table 18: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 19: North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 20: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Country/Sub-region, 2017-2031
  • Table 23: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 24: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Product Type, 2017-2031
  • Table 25: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2017-2031
  • Table 26: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2017-2031
  • Table 27: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 28: Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 29: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 30: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 31: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 33: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Product Type, 2017-2031
  • Table 34: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2017-2031
  • Table 35: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2017-2031
  • Table 36: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 37: Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 38: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 39: Latin America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 40: Latin America Albumin (as Excipient) Market Volume (Kg) Forecast, by Country/Sub-region, 2017-2031
  • Table 41: Latin America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 42: Latin America Albumin (as Excipient) Market Volume (Kg) Forecast, by Product Type, 2017-2031
  • Table 43: Latin America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2017-2031
  • Table 44: Latin America Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2017-2031
  • Table 45: Latin America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 46: Latin America Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 47: Latin America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 48: Middle East & Africa Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 49: Middle East & Africa Albumin (as Excipient) Market Volume (Kg) Forecast, by Country/Sub-region, 2017-2031
  • Table 50: Middle East & Africa Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 51: Middle East & Africa Albumin (as Excipient) Market Volume (Kg) Forecast, by Product Type, 2017-2031
  • Table 52: Middle East & Africa Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2017-2031
  • Table 53: Middle East & Africa Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2017-2031
  • Table 54: Middle East & Africa Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 55: Middle East & Africa Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2017-2031
  • Table 56: Middle East & Africa Albumin (as Excipient) Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Albumin (as Excipient) Market Volume (Kg) Forecast, 2017-2031
  • Figure 03: Global Albumin (as Excipient) Market Value Share, by Product Type, 2021
  • Figure 04: Global Albumin (as Excipient) Market Value Share, by End-user, 2021
  • Figure 05: Global Albumin (as Excipient) Market Value Share, by Application (Human Serum Albumin Applications) (2021)
  • Figure 06: Global Albumin (as Excipient) Market Value Share, by Region, 2021
  • Figure 07: Global Albumin (as Excipient) Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 08: Global Albumin (as Excipient) Market Attractiveness, by Product Type, 2022-2031
  • Figure 09: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Human Serum Albumin, 2017-2031
  • Figure 10: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Recombinant Albumin, 2017-2031
  • Figure 11: Global Albumin (as Excipient) Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 12: Global Albumin (as Excipient) Market Attractiveness, by Application, 2022-2031
  • Figure 13: Global Albumin (as Excipient) Market Value Share Analysis, by Human Serum Albumin Applications, 2021 and 2031
  • Figure 14: Global Albumin (as Excipient) Market Value Share Analysis, by Recombinant Albumin Applications, 2021 and 2031
  • Figure 15: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Drug Formulation, 2017-2031
  • Figure 16: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Drug Delivery, 2017-2031
  • Figure 17: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Vaccines, 2017-2031
  • Figure 18: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Medical Device Coating, 2017-2031
  • Figure 19: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Culture Medium & Stabilizer, 2017-2031
  • Figure 20: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Diagnostics, 2017-2031
  • Figure 21: Global Albumin (as Excipient) Market Revenue (US$ Mn), by In Vitro Fertilization, 2017-2031
  • Figure 22: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Drug Formulation, 2017-2031
  • Figure 23: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Drug Delivery, 2017-2031
  • Figure 24: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Vaccines, 2017-2031
  • Figure 25: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Medical Device Coating, 2017-2031
  • Figure 26: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Culture Medium & Stabilizer, 2017-2031
  • Figure 27: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Diagnostics, 2017-2031
  • Figure 28: Global Albumin (as Excipient) Market Revenue (US$ Mn), by In Vitro Fertilization, 2017-2031
  • Figure 29: Global Albumin (as Excipient) Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 30: Global Albumin (as Excipient) Market Attractiveness, by End-user, 2022-2031
  • Figure 31: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Industry, 2017-2031
  • Figure 32: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Specialty Centers, 2017-2031
  • Figure 33: Global Albumin (as Excipient) Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 34: Global Albumin (as Excipient) Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 35: Global Albumin (as Excipient) Market Attractiveness, by Region, 2022-2031
  • Figure 36: North America Albumin (as Excipient) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 37: North America Albumin (as Excipient) Market Value Share (%), by Country, 2021 and 2031
  • Figure 38: North America Albumin (as Excipient) Market Attractiveness, by Country, 2022-2031
  • Figure 39: North America Albumin (as Excipient) Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 40: North America Albumin (as Excipient) Market Attractiveness, by Product Type, 2022-2031
  • Figure 41: North America Albumin (as Excipient) Market Value Share Analysis, by Human Serum Albumin Applications, 2021 and 2031
  • Figure 42: North America Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2022-2031
  • Figure 43: North America Albumin (as Excipient) Market Value Share Analysis, by Recombinant Albumin Applications, 2021 and 2031
  • Figure 44: North America Albumin (as Excipient) Market Attractiveness, by Human Recombinant Applications, 2022-2031
  • Figure 45: North America Albumin (as Excipient) Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 46: North America Albumin (as Excipient) Market Attractiveness, by End-user, 2022-2031
  • Figure 47: Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 48: Europe Albumin (as Excipient) Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 49: Europe Albumin (as Excipient) Market Attractiveness, by Country/Sub-region, 2022-2031
  • Figure 50: Europe Albumin (as Excipient) Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 51: Europe Albumin (as Excipient) Market Attractiveness, by Product Type, 2022-2031
  • Figure 52: Europe Albumin (as Excipient) Market Value Share Analysis, by Human Serum Albumin Applications, 2021 and 2031
  • Figure 53: Europe Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2022-2031
  • Figure 54: Europe Albumin (as Excipient) Market Value Share Analysis, by Recombinant Albumin Applications, 2021 and 2031
  • Figure 55: Europe Albumin (as Excipient) Market Attractiveness, by Human Recombinant Applications, 2022-2031
  • Figure 56: Europe Albumin (as Excipient) Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 57: Europe Albumin (as Excipient) Market Attractiveness, by End-user, 2022-2031
  • Figure 58: Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 59: Asia Pacific Albumin (as Excipient) Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 60: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Country/Sub-region, 2022-2031
  • Figure 61: Asia Pacific Albumin (as Excipient) Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 62: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Product Type, 2022-2031
  • Figure 63: Asia Pacific Albumin (as Excipient) Market Value Share Analysis, by Human Serum Albumin Applications, 2021 and 2031
  • Figure 64: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2022-2031
  • Figure 65: Asia Pacific Albumin (as Excipient) Market Value Share Analysis, by Recombinant Albumin Applications, 2021 and 2031
  • Figure 66: Asia Pacific Albumin (as Excipient) Market Attractiveness, by Human Recombinant Applications, 2022-2031
  • Figure 67: Asia Pacific Albumin (as Excipient) Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 68: Asia Pacific Albumin (as Excipient) Market Attractiveness, by End-user, 2022-2031
  • Figure 69: Latin America Albumin (as Excipient) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 70: Latin America Albumin (as Excipient) Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 71: Latin America Albumin (as Excipient) Market Attractiveness, by Country/Sub-region, 2022-2031
  • Figure 72: Latin America Albumin (as Excipient) Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 73: Latin America Albumin (as Excipient) Market Attractiveness, by Product Type, 2022-2031
  • Figure 74: Latin America Albumin (as Excipient) Market Value Share Analysis, by Human Serum Albumin Applications, 2021 and 2031
  • Figure 75: Latin America Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2022-2031
  • Figure 76: Latin America Albumin (as Excipient) Market Value Share Analysis, by Recombinant Albumin Applications, 2021 and 2031
  • Figure 77: Latin America Albumin (as Excipient) Market Attractiveness, by Human Recombinant Applications, 2022-2031
  • Figure 78: Latin America Albumin (as Excipient) Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 79: Latin America Albumin (as Excipient) Market Attractiveness, by End-user, 2022-2031
  • Figure 80: Middle East & Africa Albumin (as Excipient) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 81: Middle East & Africa Albumin (as Excipient) Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 82: Middle East & Africa Albumin (as Excipient) Market Attractiveness, by Country/Sub-region, 2022-2031
  • Figure 83: Middle East & Africa Albumin (as Excipient) Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 84: Middle East & Africa Albumin (as Excipient) Market Attractiveness, by Product Type, 2022-2031
  • Figure 85: Middle East & Africa Albumin (as Excipient) Market Value Share Analysis, by Human Serum Albumin Applications, 2021 and 2031
  • Figure 86: Middle East & Africa Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2022-2031
  • Figure 87: Middle East & Africa Albumin (as Excipient) Market Value Share Analysis, by Recombinant Albumin Applications, 2021 and 2031
  • Figure 88: Middle East & Africa Albumin (as Excipient) Market Attractiveness, by Human Recombinant Applications, 2022-2031
  • Figure 89: Middle East & Africa Albumin (as Excipient) Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 90: Middle East & Africa Albumin (as Excipient) Market Attractiveness, by End-user, 2022-2031
  • Figure 91: Global Albumin (as Excipient) Market Share, by Company, 2021